The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

Patients with early breast cancer who are older may experience high-grade immune-related side effects after receiving immune ...

The presentation highlights XORTX recent pioneering discoveries in the field of Autosomal Dominant Polycystic Kidney Disease ...

Keros Therapeutics said on Thursday that it has voluntarily halted usage of its 3.0 milligram (mg) and 4.5 mg doses of its ...

As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...

Taiwan is accelerating efforts to eliminate hepatitis C by 2025, focusing on high-risk groups like prisoners and drug users.

New research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged 65 ...

A high-resolution CT scan revealed the foreign body (swallowed beetle nut) obstructing her airway, which had resulted in post ...

Manila: PhilHealth, the state-owned health insurer, expected to get money from Filipino taxpayers to the tune of Php150.92 ...